Other Common Ingredients: Weak Evidence, Strong Marketing Several other compounds appear regularly in GLP-1 supplement formulations, typically with minimal evidence for the specific claims made: Chromium Picolinate Marketed for insulin sensitivity and glucose metabolism, chromium shows weak and inconsistent evidence
Roberts Hepatology International.2025
The clearness of cytoplasms in some cases appears to be due to the intracellular accumulation of glycogen as characterized by strong diastase-sensitive periodic acid-Schiff positivity
Research is based on each brands own website, its published policies, and publicly available customer feedback
The 28-day rule Discard any remaining solution 28 days after reconstitution, regardless of how much is left
In the SURMOUNT-1 trial, also published in the NEJM , the results were even more striking